West Pharmaceutical: Q4 Financial Results Overview

West Pharmaceutical Services Reports Strong Fourth Quarter Results

West Pharmaceutical Services Inc., headquartered in Exton, Pennsylvania, announced a net profit of $132.1 million for the fourth quarter.

The company’s earnings translated to $1.82 per share. After adjusting for one-time and restructuring expenses, adjusted earnings reached $2.04 per share.

These results surpassed analysts’ expectations, as the consensus from seven analysts polled by Zacks Investment Research had projected earnings of $1.83 per share.

Quarterly revenue came in at $805 million, outpacing the $794.3 million estimate from six Zacks analysts.

For the full year, West Pharmaceutical Services reported a total profit of $493.7 million, or $6.79 per share, with annual revenue totaling $3.07 billion.

Looking ahead, the company anticipates full-year earnings to fall between $7.85 and $8.20 per share, with projected revenue ranging from $3.22 billion to $3.28 billion.